Literature DB >> 26068752

In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.

Carolin Anders1, Ole Niewoehner1, Martin Jinek2.   

Abstract

The programmable RNA-guided DNA cleavage activity of the bacterial CRISPR-associated endonuclease Cas9 is the basis of genome editing applications in numerous model organisms and cell types. In a binary complex with a dual crRNA:tracrRNA guide or single-molecule guide RNA, Cas9 targets double-stranded DNAs harboring sequences complementary to a 20-nucleotide segment in the guide RNA. Recent structural studies of the enzyme have uncovered the molecular mechanism of RNA-guided DNA recognition. Here, we provide protocols for electrophoretic mobility shift and fluorescence-detection size exclusion chromatography assays used to probe DNA binding by Cas9 that allowed us to reconstitute and crystallize the enzyme in a ternary complex with a guide RNA and a bona fide target DNA. The procedures can be used for further mechanistic investigations of the Cas9 endonuclease family and are potentially applicable to other multicomponent protein-nucleic acid complexes.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; Cas9; Double-strand DNA break; EMSA; Endonuclease; Fluorescence detection; Genome editing; HPLC; Macromolecular complexes; Protein–RNA interactions

Mesh:

Substances:

Year:  2015        PMID: 26068752      PMCID: PMC5074362          DOI: 10.1016/bs.mie.2015.02.008

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  48 in total

Review 1.  Analytical exclusion chromatography.

Authors:  Donald J Winzor
Journal:  J Biochem Biophys Methods       Date:  2003-06-30

2.  Strategies in RNA crystallography.

Authors:  Francis E Reyes; Andrew D Garst; Robert T Batey
Journal:  Methods Enzymol       Date:  2009-11-17       Impact factor: 1.600

3.  Crystal structure of the HCV IRES central domain reveals strategy for start-codon positioning.

Authors:  Katherine E Berry; Shruti Waghray; Stefanie A Mortimer; Yun Bai; Jennifer A Doudna
Journal:  Structure       Date:  2011-10-12       Impact factor: 5.006

4.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

Review 5.  Genome editing. The new frontier of genome engineering with CRISPR-Cas9.

Authors:  Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2014-11-28       Impact factor: 47.728

6.  Crystallization of RNA-protein complexes.

Authors:  Eiji Obayashi; Chris Oubridge; Daniel Pomeranz Krummel; Kiyoshi Nagai
Journal:  Methods Mol Biol       Date:  2007

7.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

8.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

9.  Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system.

Authors:  Baohui Chen; Luke A Gilbert; Beth A Cimini; Joerg Schnitzbauer; Wei Zhang; Gene-Wei Li; Jason Park; Elizabeth H Blackburn; Jonathan S Weissman; Lei S Qi; Bo Huang
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  13 in total

Review 1.  The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.

Authors:  Ming Shao; Tian-Rui Xu; Ce-Shi Chen
Journal:  Dongwuxue Yanjiu       Date:  2016-07-18

2.  Applications of CRISPR technologies in research and beyond.

Authors:  Rodolphe Barrangou; Jennifer A Doudna
Journal:  Nat Biotechnol       Date:  2016-09-08       Impact factor: 54.908

3.  Sequence-Directed Covalent Protein-DNA Linkages in a Single Step Using HUH-Tags.

Authors:  Klaus N Lovendahl; Amanda N Hayward; Wendy R Gordon
Journal:  J Am Chem Soc       Date:  2017-05-16       Impact factor: 15.419

4.  Francisella novicida Cas9 interrogates genomic DNA with very high specificity and can be used for mammalian genome editing.

Authors:  Sundaram Acharya; Arpit Mishra; Deepanjan Paul; Asgar Hussain Ansari; Mohd Azhar; Manoj Kumar; Riya Rauthan; Namrata Sharma; Meghali Aich; Dipanjali Sinha; Saumya Sharma; Shivani Jain; Arjun Ray; Suman Jain; Sivaprakash Ramalingam; Souvik Maiti; Debojyoti Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

5.  Enhanced Bacterial Immunity and Mammalian Genome Editing via RNA-Polymerase-Mediated Dislodging of Cas9 from Double-Strand DNA Breaks.

Authors:  Ryan Clarke; Robert Heler; Matthew S MacDougall; Nan Cher Yeo; Alejandro Chavez; Maureen Regan; Leslyn Hanakahi; George M Church; Luciano A Marraffini; Bradley J Merrill
Journal:  Mol Cell       Date:  2018-07-05       Impact factor: 17.970

6.  Target site selection and remodelling by type V CRISPR-transposon systems.

Authors:  Irma Querques; Michael Schmitz; Seraina Oberli; Christelle Chanez; Martin Jinek
Journal:  Nature       Date:  2021-11-10       Impact factor: 69.504

7.  Bacteriophage DNA glucosylation impairs target DNA binding by type I and II but not by type V CRISPR-Cas effector complexes.

Authors:  Marnix Vlot; Joep Houkes; Silke J A Lochs; Daan C Swarts; Peiyuan Zheng; Tim Kunne; Prarthana Mohanraju; Carolin Anders; Martin Jinek; John van der Oost; Mark J Dickman; Stan J J Brouns
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

Review 8.  Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.

Authors:  Peter Gee; Huaigeng Xu; Akitsu Hotta
Journal:  Stem Cells Int       Date:  2017-05-15       Impact factor: 5.443

9.  Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity.

Authors:  Christopher R Cromwell; Keewon Sung; Jinho Park; Amanda R Krysler; Juan Jovel; Seong Keun Kim; Basil P Hubbard
Journal:  Nat Commun       Date:  2018-04-13       Impact factor: 14.919

10.  Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9.

Authors:  Carolin Anders; Katja Bargsten; Martin Jinek
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.